Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Alzheimer
08. August 2026
Search
medline.ch
Alzheimer
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3586
Articles 1 - 20 / 71709
The Impact of Denoising Approaches on the Relationship Between Alzheimer's Disease Diagnostic Status and Network Topology Measures.
Hum Brain Mapp
Blujus JK, Oh H, Alzheimer's Disease Neuroimaging Initiative.
PMID: 42568124 [PubMed - indexed for MEDLINE]
Ultrasensitive detection of blood-based p-tau217 for Alzheimer's disease integrated antibody-oligonucleotide conjugates and RCA/Cas12a system.
Anal Chim Acta
Chen Y, Zhang B, Yang S, Wang P, Wang X, He H.
PMID: 42567574 [PubMed - indexed for MEDLINE]
Genetic evidence for a causal role of depression in late-onset Alzheimer disease: A Mendelian randomization study.
Medicine (Baltimore)
Chen Y, Chen X.
PMID: 42566636 [PubMed - indexed for MEDLINE]
Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.
Alzheimers Dement
Collins EC, Lu M, Beck R, Hendrix J, Hodsdon ME, Hansson O.
PMID: 42565262 [PubMed - indexed for MEDLINE]
A randomized phase 1b/2 trial of ABBV-916 in adults with early Alzheimer's disease.
Alzheimers Dement
Lynch SY, Wang Y, Wang D, Bachhav SS, Xiong H, Boiser J, Stage E, Bannon AW, Graff O, Florian H.
PMID: 42565245 [PubMed - indexed for MEDLINE]
Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy.
Dement Neurocogn Disord
Park J.
PMID: 42564518 [PubMed]
Diagnostic Accuracy of MRI-Based Artificial Intelligence Models for Distinguishing Alzheimer's Disease and Mild Cognitive Impairment From Cognitively Normal Controls: A Systematic Review and Meta-Analysis.
Dement Neurocogn Disord
Allaham SMI.
PMID: 42564476 [PubMed]
Serum elemental profile-based machine learning models for Alzheimer's disease identification and cognitive score prediction.
Neuroprotection
Liu H, Liu X, Chen Y, Pan M, Fu Y, Ma C, Ge W.
PMID: 42564343 [PubMed - as supplied by publisher]
Electroencephalography for early Alzheimer's disease diagnosis: from advanced feature engineering to interpretable ai and clinical translation.
Front Psychiatry
Chi M, Zhao A, Zhang Y, Fan L, Wang Q, Tang B, Tao M.
PMID: 42564336 [PubMed]
Ferroptosis-related biomarkers for diagnosis and mechanistic insights into Alzheimer's disease.
Front Aging Neurosci
Zhao M, Sui X, Li J, Wang Q, Sun Y, Zheng H, Li B.
PMID: 42564294 [PubMed]
The impact of long-term antiseizure treatment on cognitive decline in late-onset epileptic prodromal Alzheimer's disease: an exploratory study.
Front Aging Neurosci
Cretin B, Philippi N, Bousiges O, Dibitonto L, Blanc F.
PMID: 42564239 [PubMed]
Impact of Narrative Nursing and Cognitive Behavioral Rehabilitation on Cognitive Function and Anxiety in Patients With Alzheimer's Disease.
Geriatr Gerontol Int
Shao R, Li W, Su H, Zhou S, Lan M, Li D.
PMID: 42562777 [PubMed - indexed for MEDLINE]
The emerging role of NADPH oxidases (NOX) in Alzheimer's disease pathogenesis.
Neuroscience
Yadav A, Verma H, Kumari S, Gangwar P, Rao R, Yadav B, Kaur S, Dhiman M, Mantha AK.
PMID: 42562307 [PubMed - as supplied by publisher]
HMGB1 signalling in Alzheimer's disease: pathogenic roles and therapeutic prospects.
Int Immunopharmacol
Tyagi P, Kumari S, Sharma P, Dhapola R, Paidlewar M, Medhi B, HariKrishnaReddy D.
PMID: 42561665 [PubMed - as supplied by publisher]
Insulin resistance as a driver of neuroinflammation and oxidative stress in Alzheimer's disease: Mechanistic links and therapeutic approaches.
Biomed Pharmacother
Hajeforoosh P, Moghaddam AH, Jelodar SK.
PMID: 42561602 [PubMed - as supplied by publisher]
Cognitive and Biomarker Signatures of Late-Onset Temporal Lobe Epilepsy: Toward Non-Alzheimer Neurodegenerative Mechanisms.
Neurology
Casarini A, Ballerini A, Maramotti R, Tondelli M, Carbone C, Chiari A, Vinceti G, Bedin R, Urbano T, Malagoli M, Genovese M, Scolastico S, Giovannini G, Pugnaghi M, Orlandi N, Molinari MA, Meletti S, Zamboni G, Vaudano AE.
PMID: 42550989 [PubMed - indexed for MEDLINE]
Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer's Disease: A Systematic Review.
CNS Drugs
Brimson S, Thitilertdecha P, Kumaree KK, Brimson JM.
PMID: 42560467 [PubMed - as supplied by publisher]
Mechanisms, Biomarkers and Therapeutic Implications of Neuroinflammation in Alzheimer's Disease.
Int J Dev Neurosci
Papelian S.
PMID: 42560134 [PubMed - indexed for MEDLINE]
Advancements in non-pharmaceutical interventions for Alzheimer's disease management: an update review.
Front Aging Neurosci
Chen J, Zhang Z.
PMID: 42558626 [PubMed]
Lecanemab use in Chinese patients with Alzheimer's disease: a 12-month multicenter real-world study.
Alzheimers Dement
Wu H, Chen Q, Fang M, Tang H, Liu H, Liu J, Zhang J, Chi L, Liu S, Xin J, Leng L, Wang P, Chi S, Li Y, Chen J, Zhang L, Zhang J, Ma Q, Wang X, Meng X, Nao J, Li X, Lv Y, Jia Y, Zhao Q, Liu C, Gan J, Zhu J, Song Y, Li H, Fei M, Guo X, Liu J, Peng G, Chen X, Ji Y.
PMID: 42557932 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 71709
Page 1 of 3586
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy